Abstract:It is notorious that cancer cells alter their metabolism to adjust to harsh environments of hypoxia and nutritional starvation. Metabolic reprogramming most often occurs in the tumor microenvironment (TME). TME is defined as the cellular environment in which the tumor resides. This includes surrounding blood vessels, fibroblasts, immune cells, signaling molecules and the extracellular matrix (ECM). It is increasingly recognized that cancer cells, fibroblasts and immune cells within TME can regulate tumor progression through metabolic reprogramming. As the most significant proportion of cells among all the stromal cells that constitute TME, cancer-associated fibroblasts (CAFs) are closely associated with tumorigenesis and progression. Multitudinous studies have shown that CAFs participate in and promote tumor metabolic reprogramming and exert regulatory effects via the dysregulation of metabolic pathways. Previous studies have demonstrated that curbing the substance exchange between CAFs and tumor cells can dramatically restrain tumor growth. Emerging studies suggest that CAFs within the TME have emerged as important determinants of metabolic reprogramming. Metabolic reprogramming also occurs in the metabolic pattern of immune cells. In the meanwhile, immune cell phenotype and functions are metabolically regulated. Notably, immune cell functions influenced by metabolic programs may ultimately lead to alterations in tumor immunity. Despite the fact that multiple previous researches have been devoted to studying the interplays between different cells in the tumor microenvironment, the complicated relationship between CAFs and immune cells and implications of metabolic reprogramming remains unknown and requires further investigation. In this review, we discuss our current comprehension of metabolic reprogramming of CAFs and immune cells (mainly glucose, amino acid, and lipid metabolism) and crosstalk between them that induces immune responses, and we also highlight their contributions to tumorigenesis and progression. Furthermore, we underscore potential therapeutic opportunities arising from metabolism dysregulation and metabolic crosstalk, focusing on strategies targeting CAFs and immune cell metabolic crosstalk in cancer immunotherapy.

The multifaceted roles of small extracellular vesicles in metabolic reprogramming in the tumor microenvironments

Emerging roles of small extracellular vesicles in metabolic reprogramming and drug resistance in cancers

Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression

Small extracellular vesicles in metabolic remodeling of tumor cells: Cargos and translational application

Small Extracellular Vesicles-Mediated Cellular Interactions Between Tumor Cells and Tumor-Associated Macrophages: Implication for Immunotherapy.

The interplay between the tumor microenvironment and tumor-derived small extracellular vesicles in cancer development and therapeutic response

Cytokines and soluble mediators as architects of tumor microenvironment reprogramming in cancer therapy

The biological function of tumor-derived extracellular vesicles on metabolism

Extracellular Vesicle-Mediated Mitochondrial Reprogramming in Cancer

Exosome-mediated remodeling of the tumor microenvironment: From local to distant intercellular communication

Modulatory effects of cancer stem cell-derived extracellular vesicles on the tumor immune microenvironment

Extracellular vesicles in the tumor microenvironment: old stories, but new tales

Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment

Proteomics analysis of circulating small extracellular vesicles: Focus on the contribution of EVs to tumor metabolism

Tumor-Derived Extracellular Vesicles Regulate Cancer Progression in the Tumor Microenvironment

Tumor-derived Extracellular Vesicles: Regulators of Tumor Microenvironment and the Enlightenment in Tumor Therapy

Tumor-Derived Small Extracellular Vesicles Involved in Breast Cancer Progression and Drug Resistance

The roles of small extracellular vesicles in cancer and immune regulation and translational potential in cancer therapy

Crosstalk among long non-coding RNA, tumor-associated macrophages and small extracellular vesicles in tumorigenesis and dissemination

Extracellular vesicle-mediated crosstalk in tumor microenvironment dominates tumor fate

The Emerging Roles of Extracellular Vesicles As Communication Vehicles within the Tumor Microenvironment and Beyond